Synthesis and biological evaluation of novel hybrids of highly potent and selective a4ß2-Nicotinic acetylcholine receptor (nAChR) partial agonists
MetadataShow full item record
© 2016 Elsevier Masson SASWe previously reported the cyclopropylpyridine and isoxazolylpyridine ether scaffolds to be versatile building blocks for creating potent a4ß2 nicotinic acetylcholine receptor (nAChR) partial agonists with excellent selectivity over the a3ß4 subtype. In our continued efforts to develop therapeutic nicotinic ligands, seven novel hybrid compounds were rationally designed, synthesized, and evaluated in [3H]epibatidine binding competition studies. Incorporation of a cyclopropane- or isoxazole-containing side chain onto the 5-position of 1-(pyridin-3-yl)-1,4-diazepane or 2-(pyridin-3-yl)-2,5-diazabicyclo[2.2.1]heptane led to highly potent and selective a4ß2* nAChR partial agonists with Ki values of 0.5–51.4 nM for a4ß2 and negligible affinities for a3ß4 and a7. Moreover, compounds 21, 25, and 30 maintained the functional profiles (EC50 and IC50 values of 15–50 nM) of the parent azetidine-containing compounds 3 and 4 in the 86Rb+ ion flux assays. In vivo efficacy of the most promising compound 21 was confirmed in the mouse SmartCube® platform and classical forced swim tests, supporting the potential use of a4ß2 partial agonists for treatment of depression.
Showing items related by title, author, creator and subject.
Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim testClark, J.; Alves, S.; Gundlah, C.; Rocha, B.; Birzin, E.; Cai, S.; Flick, R.; Hayes, E.; Ho, K.; Warrier, Sudha; Pai, L.; Yudkovitz, J.; Fleischer, R.; Colwell, L.; Li, S.; Wilkinson, H.; Schaeffer, J.; Wilkening, R.; Mattingly, E.; Hammond, M.; Rohrer, S. (2012)Estrogen acts through two molecularly distinct receptors termed estrogen receptor alpha (ERa) and estrogen receptor beta (ERß) which bind estradiol with similar affinities and mediate the effects of estrogen throughout ...
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agentsCheng, J.; Giguère, P.; Onajole, O.; Lv, W.; Gaisin, A.; Gunosewoyo, Hendra; Schmerberg, C.; Pogorelov, V.; Rodriguiz, R.; Vistoli, G.; Wetsel, W.; Roth, B.; Kozikowski, A. (2015)The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused ...
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapyDai, X.; Zhang, J.; Arfuso, Frank; Chinnathambi, A.; Zayed, M.; Alharbi, S.; Kumar, A.; Ahn, K.; Sethi, G. (2015)© 2015 by the Society for Experimental Biology and Medicine Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to selectively induce apoptotic cell death in various tumor cells by engaging its ...